Drugs / Bacillus Calmette-Guerin: Strain TICE
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05037279 Comparator | Apr 2024 → Feb 2029 expected | non-invasive bladder urothelial carcinoma | Verity Pharmaceuticals Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus Calmette-Guerin: Strain TICE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05037279 ↗ |
| Route | Other | “bladder instillation” NCT05037279 ↗ |